ANI PHARMACEUTICALS INC 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 16, 2015
Insider Transaction Report
Form 4
MARSHBANKS TRACY
Director
Transactions
- Sale
Common Stock
2015-03-12$63.00/sh−143,516$9,041,508→ 375,829 total(indirect: See Footnote 1) - Sale
Common Stock
2015-03-12$63.00/sh−58,265$3,670,695→ 152,579 total(indirect: See Footnote 3) - Sale
Common Stock
2015-03-12$63.00/sh−5,978$376,614→ 15,656 total(indirect: See Footnote 2) - Sale
Common Stock
2015-03-12$63.00/sh−2,241$141,183→ 5,870 total(indirect: See Footnote 4)
Footnotes (4)
- [F1]1: Held by: FA Private Equity Fund IV, L.P., of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
- [F2]2: Held by: FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
- [F3]3: Held by: The Productivity Fund IV Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
- [F4]4: Held by: The Productivity Fund IV Advisors Fund Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).